These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 23573289
1. Evolution of hepatic glucose metabolism: liver-specific glucokinase deficiency explained by parallel loss of the gene for glucokinase regulatory protein (GCKR). Wang ZY, Jin L, Tan H, Irwin DM. PLoS One; 2013; 8(4):e60896. PubMed ID: 23573289 [Abstract] [Full Text] [Related]
2. Role of glucokinase in the subcellular localization of glucokinase regulatory protein. Jin L, Guo T, Li Z, Lei Z, Li H, Mao Y, Wang X, Zhou N, Zhang Y, Hu R, Zhang X, Niu G, Irwin DM, Tan H. Int J Mol Sci; 2015 Apr 02; 16(4):7377-93. PubMed ID: 25849650 [Abstract] [Full Text] [Related]
3. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, Gloyn AL. Hum Mol Genet; 2009 Nov 01; 18(21):4081-8. PubMed ID: 19643913 [Abstract] [Full Text] [Related]
4. A hepatic protein modulates glucokinase activity in fish and avian liver: a comparative study. Polakof S, Míguez JM, Soengas JL. J Comp Physiol B; 2009 Jul 01; 179(5):643-52. PubMed ID: 19247671 [Abstract] [Full Text] [Related]
5. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis. Arden C, Petrie JL, Tudhope SJ, Al-Oanzi Z, Claydon AJ, Beynon RJ, Towle HC, Agius L. Diabetes; 2011 Dec 01; 60(12):3110-20. PubMed ID: 22013014 [Abstract] [Full Text] [Related]
6. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Tam CH, Ma RC, So WY, Wang Y, Lam VK, Germer S, Martin M, Chan JC, Ng MC. Diabetes; 2009 Mar 01; 58(3):765-9. PubMed ID: 19073768 [Abstract] [Full Text] [Related]
7. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Rees MG, Wincovitch S, Schultz J, Waterstradt R, Beer NL, Baltrusch S, Collins FS, Gloyn AL. Diabetologia; 2012 Jan 01; 55(1):114-22. PubMed ID: 22038520 [Abstract] [Full Text] [Related]
8. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits. Singh C, Jin B, Shrestha N, Markhard AL, Panda A, Calvo SE, Deik A, Pan X, Zuckerman AL, Ben Saad A, Corey KE, Sjoquist J, Osganian S, AminiTabrizi R, Rhee EP, Shah H, Goldberger O, Mullen AC, Cracan V, Clish CB, Mootha VK, Goodman RP. Cell Metab; 2024 Jan 02; 36(1):144-158.e7. PubMed ID: 38101397 [Abstract] [Full Text] [Related]
9. Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23. Hayward BE, Fantes JA, Warner JP, Intody S, Leek JP, Markham AF, Bonthron DT. Mamm Genome; 1996 Jun 02; 7(6):454-8. PubMed ID: 8662230 [Abstract] [Full Text] [Related]
10. Current Insight on the Role of Glucokinase and Glucokinase Regulatory Protein in Diabetes. Paliwal A, Paliwal V, Jain S, Paliwal S, Sharma S. Mini Rev Med Chem; 2024 Jun 02; 24(7):674-688. PubMed ID: 37612862 [Abstract] [Full Text] [Related]
11. Evolution of glucose utilization: glucokinase and glucokinase regulator protein. Irwin DM, Tan H. Mol Phylogenet Evol; 2014 Jan 02; 70():195-203. PubMed ID: 24075984 [Abstract] [Full Text] [Related]
12. Dengue Virus dependence on glucokinase activity and glycolysis Confers Sensitivity to NAD(H) biosynthesis inhibitors. Ogire E, Perrin-Cocon L, Figl M, Kundlacz C, Jacquemin C, Hubert S, Aublin-Gex A, Toesca J, Ramière C, Vidalain PO, Mathieu C, Lotteau V, Diaz O. Antiviral Res; 2024 Aug 02; 228():105939. PubMed ID: 38909960 [Abstract] [Full Text] [Related]
13. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity. García-Herrero CM, Galán M, Vincent O, Flández B, Gargallo M, Delgado-Alvarez E, Blázquez E, Navas MA. Diabetologia; 2007 Feb 02; 50(2):325-33. PubMed ID: 17186219 [Abstract] [Full Text] [Related]
14. Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice. Wang R, Gao H, Xu W, Li H, Mao Y, Wang Y, Guo T, Wang X, Song R, Li Z, Irwin DM, Niu G, Tan H. Gene; 2013 Mar 10; 516(2):248-54. PubMed ID: 23291412 [Abstract] [Full Text] [Related]
15. Estimating hepatic glucokinase activity using a simple model of lactate kinetics. Stefanovski D, Youn JH, Rees M, Watanabe RM, Ader M, Ionut V, Jackson AU, Boehnke M, Collins FS, Bergman RN. Diabetes Care; 2012 May 10; 35(5):1015-20. PubMed ID: 22456868 [Abstract] [Full Text] [Related]
16. Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age. Guo T, Mao Y, Li H, Wang X, Xu W, Song R, Jia J, Lei Z, Irwin DM, Niu G, Tan H. Biomed Pharmacother; 2012 Dec 10; 66(8):587-96. PubMed ID: 23085254 [Abstract] [Full Text] [Related]
17. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326. Ford BE, Chachra SS, Rodgers K, Moonira T, Al-Oanzi ZH, Anstee QM, Reeves HL, Schattenberg JM, Fairclough RJ, Smith DM, Tiniakos D, Agius L. Mol Metab; 2023 Jun 10; 72():101722. PubMed ID: 37031802 [Abstract] [Full Text] [Related]
18. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes. Rees MG, Ng D, Ruppert S, Turner C, Beer NL, Swift AJ, Morken MA, Below JE, Blech I, NISC Comparative Sequencing Program, Mullikin JC, McCarthy MI, Biesecker LG, Gloyn AL, Collins FS. J Clin Invest; 2012 Jan 10; 122(1):205-17. PubMed ID: 22182842 [Abstract] [Full Text] [Related]
19. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes. Tracz A, Madzio J, Gnys P, Malachowska B, Borowiec M, Wyka K, Jarosz-Chobot P, Mysliwiec M, Szadkowska A, Mlynarski W, Fendler W, PolPeDiab Study Group. Exp Clin Endocrinol Diabetes; 2014 Oct 10; 122(9):503-9. PubMed ID: 24918535 [Abstract] [Full Text] [Related]
20. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019). Wang K, Shi M, Yang A, Fan B, Tam CHT, Lau E, Luk AOY, Kong APS, Ma RCW, Chan JCN, Chow E. Diabetes Res Clin Pract; 2022 Nov 10; 193():110118. PubMed ID: 36243233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]